Global Overview
During Q4 2025, the furosemide price chart remained firm across major pharmaceutical-producing regions, supported by consistent healthcare demand and balanced production levels. Stable availability of active pharmaceutical ingredient (API) feedstocks, reliable manufacturing operations, and steady procurement from healthcare providers ensured adequate supply. Regional price differences reflected production costs, regulatory compliance, logistics, and local pharmaceutical consumption patterns.
USA Furosemide Prices Movement 2025
The USA recorded furosemide prices at USD 87,060/MT during Q4 2025. Demand from pharmaceutical manufacturers, hospitals, healthcare institutions, and retail pharmacies remained stable. Balanced inventories, reliable imports, and consistent procurement activity supported firm pricing throughout the quarter.
China Furosemide Prices Movement 2025
China reported furosemide prices of USD 77,977/MT during Q4 2025, the lowest among the assessed regions. Stable API manufacturing, adequate raw material availability, and strong export activity maintained competitive regional pricing. Consistent pharmaceutical production and balanced inventories supported overall supply conditions.
Germany Furosemide Prices Movement 2025
Germany registered furosemide prices at USD 95,408/MT during Q4 2025. Demand from pharmaceutical companies, hospitals, and healthcare providers remained resilient. High manufacturing standards, regulatory compliance requirements, and stable production supported firm regional pricing during the reporting period.
India Furosemide Prices Movement 2025
India recorded furosemide prices at USD 92,121/MT during Q4 2025. Demand from generic pharmaceutical manufacturers, export markets, and domestic healthcare applications remained steady. Adequate API production capacity, balanced inventories, and efficient supply chains supported stable pricing.
Brazil Furosemide Prices Movement 2025
Brazil recorded the highest assessed furosemide price at USD 97,485/MT during Q4 2025. Demand from hospitals, pharmaceutical distributors, and healthcare providers remained consistent. Higher import dependence, transportation costs, and regulatory compliance expenses contributed to elevated regional pricing despite balanced supply conditions.
Get the Real-Time Prices Analysis:
https://www.imarcgroup.com/furosemide-pricing-report/requestsample
Note: The analysis can be tailored to align with the customer’s specific needs.
We Also Provide News and Historical Data of Furosemide:
- Historical furosemide price assessments across major global regions.
- Quarterly and annual pricing trend analysis.
- Regional and global supply-demand developments.
- Comparative pricing evaluations across producing and consuming countries.
- Forecast comparisons and long-term trend assessments.
- Historical datasets for procurement and strategic planning.
- Customized pricing intelligence reports tailored to specific business requirements.
What is Furosemide?
Furosemide is a loop diuretic active pharmaceutical ingredient (API) widely used to treat edema associated with heart failure, liver disease, kidney disorders, and hypertension. It is produced through controlled chemical synthesis under strict pharmaceutical manufacturing standards to ensure high purity and therapeutic efficacy. Furosemide is formulated into tablets, oral solutions, and injectable products for hospital and outpatient care, making it one of the most commonly prescribed diuretic medications worldwide.
Factors Affecting Furosemide Prices
- API raw material costs.
- Pharmaceutical manufacturing expenses.
- Regulatory compliance requirements.
- Healthcare and pharmaceutical demand.
- Energy and utility costs.
- Transportation and logistics expenses.
- Export and import dynamics.
- Inventory levels.
- Production capacity utilization.
- Pharmaceutical quality standards.
Supply and Prices Overview – Q4 2025
Global furosemide supply remained balanced during Q4 2025 as manufacturers maintained stable production supported by adequate API feedstock availability. Demand from pharmaceutical companies, hospitals, and healthcare providers remained consistent. Regional pricing reflected manufacturing costs, logistics, regulatory compliance, and downstream pharmaceutical consumption.
Furosemide Price Index
The furosemide price index remained firm during Q4 2025. Brazil recorded the highest assessed price at USD 97,485/MT, followed by Germany at USD 95,408/MT, India at USD 92,121/MT, the USA at USD 87,060/MT, and China at USD 77,977/MT. Regional price differences reflected production economics, logistics, and healthcare demand.
Recent News – Q4 2025
During Q4 2025, pharmaceutical manufacturers continued investing in API production efficiency, quality assurance systems, and regulatory compliance. Industry participants focused on strengthening supply chain resilience, expanding manufacturing capacity, and maintaining uninterrupted supply for essential medicines across global healthcare systems.
Furosemide Price Trend – Q4 2025
Furosemide prices remained stable to firm during Q4 2025, supported by balanced production, reliable raw material availability, and steady pharmaceutical demand. Consistent procurement by healthcare providers and adequate inventories contributed to stable pricing across major producing and consuming regions.
Future Outlook for Furosemide
The outlook for furosemide remains positive, supported by increasing healthcare expenditure, expanding pharmaceutical manufacturing, growing access to essential medicines, and rising demand for cardiovascular and renal therapies. Continued investments in pharmaceutical production capacity and regulatory compliance are expected to support long-term supply.
Current Demand for Furosemide
Current demand for furosemide is driven by hospitals, clinics, retail pharmacies, pharmaceutical manufacturers, cardiovascular treatment, renal disease management, hypertension therapy, emergency healthcare services, and public health programs.
Uses of Furosemide
- Treatment of edema.
- Heart failure management.
- Hypertension treatment.
- Kidney disease therapy.
- Liver disease-related fluid retention.
- Hospital emergency care.
- Oral pharmaceutical formulations.
- Injectable pharmaceutical products.
- Clinical healthcare applications.
- Pharmaceutical API manufacturing.
Key Coverage:
- Market Analysis
- Market Breakup by Region
- Demand Supply Analysis by Type
- Demand Supply Analysis by Application
- Price Analysis
- Price Trends by Region
- Factors influencing the Price Trends
- Competitive Landscape
- Recent Developments
How IMARC Pricing Database Can Help
The latest IMARC Group study, “Furosemide Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition,” presents a detailed analysis of Furosemide price trend, offering key insights into global Furosemide market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.
The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Furosemide demand, illustrating how consumer behavior and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.
About Us:
IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC’s data-driven approach helps businesses navigate complex markets with precision and confidence.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
